In that situation I would tend to advise against, with a retest in
5 years time; but if the patient insisted I might think about
treating
**************************************************************************************
Prof. Tim
Reynolds
Consultant Chemical Pathologist / Divisional Medical
Director (CH&CSS) / R&D Lead,
Burton Hospitals NHS
Foundation Trust
work tel: 01283 511511 ext 4035
work fax: 01283
593064
work email: [log in to unmask]
work URL:
www.burtonhospitals.nhs.uk
This e-mail, and any files transmitted
with it, are confidential and intended solely for the use of the individual to
whom it is addressed. If you are not the intended recipient please destroy this
message, delete any copies held on your systems, and notify the sender
immediately. You should not retain copy or use this e-mail for any purpose, nor
disclose all or any part of its content to any other person. If you have
received this e-mail in error, please notify me on 01283 511511 Ext
4035
[Picture of
tree not available]
Please consider the environment
before printing this e-mail
Hello
A question to the UK lipid clinics!
Do you base the decision to start a statin mainly based on QRISK2?
As far as I can see NICE CG181 purely talks about primary prevention using
a risk score. Do you start a statin even if chol = high but Q-Risk score =
low?
eg 41 year old female
Chol = 7.6
Chol/HDL ratio 7.4
but Q Risk 2 = 4%
No Family history CVD / she is well / no signs of FH / no secondary causes
of chol identified
Many thanks
Rob